91AV

Introduction

Circumstance such as high manufacturing complexities and costs, rigorous regulatory requirements in countries, and innovative strategies by biologic drug manufacturers to restrict the entry of new players are restraining the growth of this market.
Gain Latest Insights On:

• Learn the current global regulatory guidelines and considerations for developing and bringing the next generation of Biosimilars to the market
• Know the strategies in place in developing and manufacturing biosimilars in emerging markets
• Emerging Markets: Challenges and Benefits in Investing in Emerging Markets
• Establishing and integration of biosimilarity and comparability into developing Biosimilars
• Identify challenges encountered with Extrapolations and interchangeability, assessing immunogenicity and Pharmacovigilance
• Explore CMC regulatory challenges and considerations for Biosimilars drug development and manufacturing
• Study the pre-clinical and clinical challenges associated with the development of biosimilars
• The importance of establishing partnerships and successful collaboration for Biosimilars business
• Learn the latest updates, trends and current Biosimilars market situations in different regions
• What does the future hold for Biosimilars and Biologics

You will meet: Chief Executives, Executive Directors, Vice Presidents, Head Team Leaders and Manager

Useful links

Venue

Hilton Philadelphia City Avenue

Hilton Philadelphia City Avenue, 4200 City Avenue, Philadelphia, 19131, United States

Useful links

Organised by

Paradigm Global Events

Contact information

Jocelyn Raguindin
Paradigm Global Events
Studio 314, 3rd Floor, ScreenWorks 22 Highbury Grove, Islington,
2035671321
Contact us by email

---